ScreenPoint Medical and Ferrum Health have partnered to offer ScreenPoint’s Transpara Breast AI Suite on Ferrum Health's Model Hub.
Ferrum Health’s vendor-neutral clinical AI governance suite validates and monitors clinical AI models within a health system's owned, secure environment. The platform enables healthcare organizations to transition from one-off AI deployments to a single foundation to deploy, manage, and measure AI across service lines while maintaining full control of data, security, and evidence, the companies said.
Transpara Breast AI is designed to be a “second reader” for both 2D and 3D mammography, and includes Transpara Detection, Transpara Density, and Temporal Comparison. According to ScreenPoint, Transpara Detection improved cancer detection rates by up to 29% overall in a randomized controlled trial across variables including breast density, patient ethnicity, and radiologist experience level.
